PE20030817A1 - Composiciones farmaceuticas de mesilato de zoniporida y procedimientos para mejorar la solubilidad de la zoniporida - Google Patents
Composiciones farmaceuticas de mesilato de zoniporida y procedimientos para mejorar la solubilidad de la zoniporidaInfo
- Publication number
- PE20030817A1 PE20030817A1 PE2003000085A PE2003000085A PE20030817A1 PE 20030817 A1 PE20030817 A1 PE 20030817A1 PE 2003000085 A PE2003000085 A PE 2003000085A PE 2003000085 A PE2003000085 A PE 2003000085A PE 20030817 A1 PE20030817 A1 PE 20030817A1
- Authority
- PE
- Peru
- Prior art keywords
- zoniporida
- compound
- solubility
- mesilate
- refers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A UN METODO PARA AUMENTAR LA SOLUBILIDAD DE ZONIPORIDA (N-(5-CICLOPROPIL-1-QUINOLIN-5-IL-1H-PIRAZOL-4-CARBONIL)-GUANIDINA DE FORMULA I) QUE COMPRENDE TRATAR EL COMPUESTO CON ACIDO METANOSULFONICO EN PRESENCIA DE UN DILUYENTE ACUOSO FORMANDO UNA SOLUCION QUE TIENE UN pH EN EL INTERVALO DE 2 A 3,5; TAMBIEN SE REFIERE A UNA COMPOSICION QUE COMPRENDE LA SAL MESILATO DEL COMPUESTO; UN DILUYENTE ACUOSO, ACIDO METANOSULFONICO; Y EXCIPIENTES TAL COMO ANTIOXIDANTES; REGULADORES DE TONICIDAD, AGENTES DE AUMENTO DE VOLUMEN (AZUCARES, POLIALCOHOLES, AMINOACIDOS, POLIMEROS, POLISACARIDOS), TAMPONES, CONSERVANTES; SIENDO LA RELACION MOLAR DEL ACIDO METANOSULFONICO AL COMPUESTO DE 1 A 2. ZONIPORIDA ES UN INHIBIDOR DEL INTERCAMBIADOR-1 DE SODIO E HIDROGENO Y PUEDE SER UTIL PARA REDUCIR EL DANO DEL TEJIDO RESULTANTE DE ISQUEMIA PERIOPERATORIA DE MIOCARDIO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35302502P | 2002-01-30 | 2002-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030817A1 true PE20030817A1 (es) | 2003-10-04 |
Family
ID=27663165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000085A PE20030817A1 (es) | 2002-01-30 | 2003-01-28 | Composiciones farmaceuticas de mesilato de zoniporida y procedimientos para mejorar la solubilidad de la zoniporida |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20030149075A1 (es) |
| EP (1) | EP1472242A1 (es) |
| JP (1) | JP2005521670A (es) |
| AR (1) | AR038322A1 (es) |
| BR (1) | BR0307195A (es) |
| CA (1) | CA2472342A1 (es) |
| DO (1) | DOP2003000569A (es) |
| GT (1) | GT200300012A (es) |
| HN (1) | HN2003000050A (es) |
| MX (1) | MXPA04006615A (es) |
| PA (1) | PA8564501A1 (es) |
| PE (1) | PE20030817A1 (es) |
| SV (1) | SV2004001470A (es) |
| TW (1) | TW200302721A (es) |
| UY (1) | UY27624A1 (es) |
| WO (1) | WO2003064409A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3672571T (lt) | 2017-08-25 | 2021-12-10 | Pfizer Inc. | Farmacinė vandeninė vaisto forma, apimanti 1-(4-{[4-(dimetilamino)piperidin-1-il]karbonil}fenil)-3-[4-(4,6-dimorfolin-4-il-1,3,5-triazin-2-il)fenil]karbamidą |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU739403B2 (en) * | 1998-02-27 | 2001-10-11 | Pfizer Products Inc. | N-((substituted five-membered di- or triaza diunsaturated ring)carbonyl) guanidine derivatives for the treatment of ischemia |
| UA72002C2 (en) * | 1999-10-29 | 2005-01-17 | Pfizer Prod Inc | Inhibitors crystals of sodium-hydrogen exchange of 1 type, a method for the preparation thereof (variants), a pharmaceuticalcomposition based thereon and a method for the reduction of tissue damage |
-
2003
- 2003-01-20 CA CA002472342A patent/CA2472342A1/en not_active Abandoned
- 2003-01-20 EP EP03700406A patent/EP1472242A1/en not_active Withdrawn
- 2003-01-20 MX MXPA04006615A patent/MXPA04006615A/es not_active Application Discontinuation
- 2003-01-20 BR BR0307195-2A patent/BR0307195A/pt not_active Application Discontinuation
- 2003-01-20 JP JP2003564032A patent/JP2005521670A/ja active Pending
- 2003-01-20 WO PCT/IB2003/000146 patent/WO2003064409A1/en not_active Ceased
- 2003-01-23 GT GT200300012A patent/GT200300012A/es unknown
- 2003-01-27 UY UY27624A patent/UY27624A1/es not_active Application Discontinuation
- 2003-01-28 HN HN2003000050A patent/HN2003000050A/es unknown
- 2003-01-28 PE PE2003000085A patent/PE20030817A1/es not_active Application Discontinuation
- 2003-01-28 AR ARP030100239A patent/AR038322A1/es unknown
- 2003-01-28 DO DO2003000569A patent/DOP2003000569A/es unknown
- 2003-01-29 TW TW092102042A patent/TW200302721A/zh unknown
- 2003-01-29 SV SV2003001470A patent/SV2004001470A/es not_active Application Discontinuation
- 2003-01-30 US US10/354,288 patent/US20030149075A1/en not_active Abandoned
- 2003-01-30 PA PA20038564501A patent/PA8564501A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003064409A1 (en) | 2003-08-07 |
| UY27624A1 (es) | 2003-08-29 |
| EP1472242A1 (en) | 2004-11-03 |
| HN2003000050A (es) | 2003-08-22 |
| DOP2003000569A (es) | 2003-08-15 |
| BR0307195A (pt) | 2004-11-03 |
| SV2004001470A (es) | 2004-05-07 |
| US20030149075A1 (en) | 2003-08-07 |
| AR038322A1 (es) | 2005-01-12 |
| PA8564501A1 (es) | 2003-09-17 |
| GT200300012A (es) | 2003-08-28 |
| MXPA04006615A (es) | 2004-10-04 |
| CA2472342A1 (en) | 2003-08-07 |
| TW200302721A (en) | 2003-08-16 |
| JP2005521670A (ja) | 2005-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE41495A1 (es) | N-alquilcarboxilatos de piperidinilo 3,4,4-trisustituidos e intermedios | |
| MX9701229A (es) | Antifungicos de tetrahidrofurano. | |
| PE20001644A1 (es) | Composicion de un derivado de (5-aril-1,2,4-tiadiazol)-3-il tiourea o un derivado de (5-aril-1,2,4-tiadiazol)-3-il urea para tratar infecciones virales | |
| JOP20220195A1 (ar) | تركيبة حمض الكبريتيك وإستخداماتها | |
| PE20100447A1 (es) | Solucion acuosa inyectable que contiene 4-[[(7r)-8-isopropil-7-etil-5,6,7,8-tetrahidro-5-metil-6-oxo-tetrahidropteridin-2-il]amino]-3-metoxi-n-[(1-ciclopropil-4-piperazinil)fenil]benzamida | |
| PE20081737A1 (es) | Procedimiento de preparacion de un derivado de benzimidazol | |
| JO2256B1 (en) | Renin inhibitors | |
| BRPI0418245B8 (pt) | composto derivado de nitróxi de prostaglandina, processo para preparar dito composto, composição farmacêutica compreendendo dito composto e usos destes | |
| ES2132676T3 (es) | Composiciones de peroxigeno. | |
| PL363452A1 (en) | 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical | |
| ATE404176T1 (de) | Stabilisierte lyophilisierte zubereitungen mit gewebefaktor-inhibitor (tfpi) oder varianten des gewebefaktor-inhibitors | |
| DE69912279D1 (de) | 5-ht1f agonisten | |
| EA201170607A1 (ru) | Акриламидопроизводные, применимые как ингибиторы перехода митохондриальной проницаемости | |
| NO20054465L (no) | Topiske L-karnitinblandinger | |
| EA200000804A1 (ru) | Мета-азациклические соединения аминобензойной кислоты и их производные, являющиеся ингибиторами интегрина | |
| MA30819B1 (fr) | Nouvelle diphenylazetidinone substituee par l'acide piperazin-1-sulfonique et presentant des proprietes pharmacologiques ameliorees | |
| MX2022007583A (es) | Nuevas composiciones de ácido modificado. | |
| MXPA03011480A (es) | Una preparacion farmaceutica acuosa de cilostazol para uso parenteral. | |
| AR044019A1 (es) | Proceso para la preparacion de 2-cianopirrolidinas n-sustituidas | |
| UA101996C2 (ru) | Соединение, которое содержит интерлейкин-1 и пептид | |
| TR200100636T2 (tr) | Fosfoglikolipid ve bunun kullanım yöntemleri. | |
| PE20030817A1 (es) | Composiciones farmaceuticas de mesilato de zoniporida y procedimientos para mejorar la solubilidad de la zoniporida | |
| MX2023007287A (es) | N-(2-(4-cianotiazolidin-3-il)-2-oxoetil)-quinolin-4-carboxamidas. | |
| PE20050310A1 (es) | Derivados del acido 3-(1-[3-(1,3--benzotiazol-6-il)propilcarbamoil]cicloalquil)propanoico como inhibidores de nep | |
| PE20121468A1 (es) | Combinacion triple para reduccion de presion intraocular |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |